What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
Polypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it di...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4388504?pdf=render |
| _version_ | 1818925005104218112 |
|---|---|
| author | Barbara Farrell Corey Tsang Lalitha Raman-Wilms Hannah Irving James Conklin Kevin Pottie |
| author_facet | Barbara Farrell Corey Tsang Lalitha Raman-Wilms Hannah Irving James Conklin Kevin Pottie |
| author_sort | Barbara Farrell |
| collection | DOAJ |
| description | Polypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (≥ 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly. |
| first_indexed | 2024-12-20T02:34:20Z |
| format | Article |
| id | doaj.art-58b15724a9ac4469b1f9b3a5848ca7b8 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T02:34:20Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-58b15724a9ac4469b1f9b3a5848ca7b82022-12-21T19:56:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012224610.1371/journal.pone.0122246What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.Barbara FarrellCorey TsangLalitha Raman-WilmsHannah IrvingJames ConklinKevin PottiePolypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (≥ 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly.http://europepmc.org/articles/PMC4388504?pdf=render |
| spellingShingle | Barbara Farrell Corey Tsang Lalitha Raman-Wilms Hannah Irving James Conklin Kevin Pottie What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. PLoS ONE |
| title | What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. |
| title_full | What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. |
| title_fullStr | What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. |
| title_full_unstemmed | What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. |
| title_short | What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. |
| title_sort | what are priorities for deprescribing for elderly patients capturing the voice of practitioners a modified delphi process |
| url | http://europepmc.org/articles/PMC4388504?pdf=render |
| work_keys_str_mv | AT barbarafarrell whatareprioritiesfordeprescribingforelderlypatientscapturingthevoiceofpractitionersamodifieddelphiprocess AT coreytsang whatareprioritiesfordeprescribingforelderlypatientscapturingthevoiceofpractitionersamodifieddelphiprocess AT lalitharamanwilms whatareprioritiesfordeprescribingforelderlypatientscapturingthevoiceofpractitionersamodifieddelphiprocess AT hannahirving whatareprioritiesfordeprescribingforelderlypatientscapturingthevoiceofpractitionersamodifieddelphiprocess AT jamesconklin whatareprioritiesfordeprescribingforelderlypatientscapturingthevoiceofpractitionersamodifieddelphiprocess AT kevinpottie whatareprioritiesfordeprescribingforelderlypatientscapturingthevoiceofpractitionersamodifieddelphiprocess |